ResearcherHackensack Meridian HealthNo recent work listed

Ayrton Bangolo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2133-2480; OpenAlex author ID A5068224901. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights. Co-author DOI 10.3748/wjg.v29.i25.3984 ↗
Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States. Co-author DOI 10.5306/wjco.v13.i11.907 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Simcha I Weissman · 2 shared papers, 2022–2023 · strength 0.31
- Paper Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the … DOI 10.5306/wjco.v13.i11.907 ↗
- Paper Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights. DOI 10.3748/wjg.v29.i25.3984 ↗
Daniel Lew · 1 shared paper, 2022 · strength 0.16
- Paper Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the … DOI 10.5306/wjco.v13.i11.907 ↗
Stephen Jacob Pandol · 1 shared paper, 2022 · strength 0.16
- Paper Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the … DOI 10.5306/wjco.v13.i11.907 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.